Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.101
Buy
RSI(14)
56.101
Neutral
STOCH(KDJ)(9,3,3)
69.835
Neutral
ATR(14)
0.541
High Vlolatility
CCI(14)
36.759
Neutral
Williams %R
37.572
Buy
TRIX(12,20)
0.360
Sell
StochRSI(14)
0.000
Sell
Cellebrite DI Ltd
CLBT18.780USD
+0.040+0.22%
Market hours （ET）Quotes delayed by 15 min
4.59BMarket Cap
48.59P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Cellebrite DI Ltd
Currency: USD Updated: 2025-12-24Key Insights
Cellebrite DI Ltd's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 26/482 in the Software & IT Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 24.71.In the medium term, the stock price is expected to remain stable.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Cellebrite DI Ltd's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
8
analysts
Buy
Current Rating
24.714
Target Price
+36.54%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Cellebrite DI Ltd Highlights
StrengthsRisks
Cellebrite DI Ltd is an Israel-based company engaged primarily in the software sector. The Company is committed to providing a Digital Intelligence (DI) platform for managing DI in legally sanctioned investigations. The Company provides solutions for the public and private sectors, enabling organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. The Company's platform and solutions transform how customers collect, review, analyze and manage data in legally sanctioned investigations. The Company aims to enable its customers to protect and save lives, accelerate justice, and preserve privacy in communities around the world.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 48.24% year-on-year.
Overvalued
The company’s latest PE is 48.48, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 134.83M shares, increasing 0.05% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 77.92K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.69.
Financial Health
Currency: USD Updated: 2025-12-24The current financial score of Cellebrite DI Ltd is 8.72, ranking 48/482 in the Software & IT Services industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 126.03M, representing a year-over-year increase of 17.94%, while its net profit experienced a year-over-year increase of 109.75%.
Score
Financials
9.77
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
8.72
Operational Efficiency
8.75
Growth Potential
8.91
Shareholder Returns
7.42
Cellebrite DI Ltd's Company Valuation
Currency: USD Updated: 2025-12-24The current valuation score of Cellebrite DI Ltd is 7.28, ranking 281/482 in the Software & IT Services industry. Its current P/E ratio is 48.48, which is 19.49% below the recent high of 57.93 and 169.76% above the recent low of -33.82.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 26/482
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2025-12-24The current earnings forecast score of Cellebrite DI Ltd is 8.50, ranking 36/482 in the Software & IT Services industry. The average price target for Cellebrite DI Ltd is 24.00, with a high of 28.00 and a low of 23.00.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
8
analysts
Buy
Current Rating
24.714
Target Price
+36.54%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
241
Total
9
Median
12
Average
Company name
Ratings
Analysts
Cellebrite DI Ltd
CLBT
8
Microsoft Corp
MSFT
64
CrowdStrike Holdings Inc
CRWD
54
Palo Alto Networks Inc
PANW
54
Zscaler Inc
ZS
48
ServiceNow Inc
NOW
47
1
2
3
...
48
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2025-12-24The current price momentum score of Cellebrite DI Ltd is 9.36, ranking 35/482 in the Software & IT Services industry. Currently, the stock price is trading between the resistance level at 19.90 and the support level at 17.08, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
18.954
Sell
MA10
18.711
Buy
MA20
18.261
Buy
MA50
17.744
Buy
MA100
17.318
Buy
MA200
17.269
Buy
Institutional Confidence
Currency: USD Updated: 2025-12-24The current institutional shareholding score of Cellebrite DI Ltd is 5.00, ranking 225/482 in the Software & IT Services industry. The latest institutional shareholding proportion is 62.11%, representing a quarter-over-quarter decrease of 2.39%. The largest institutional shareholder is James Simons, holding a total of 2.90M shares, representing 1.19% of shares outstanding, with 8.91% increase in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Risk Assessment
Currency: USD Updated: 2025-12-24The current risk assessment score of Cellebrite DI Ltd is 7.03, ranking 100/482 in the Software & IT Services industry. The company's beta value is 1.27. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.
Score
Beta vs S&P 500 index
1.27
VaR
+4.34%
240-Day Maximum Drawdown
+48.00%
240-Day Volatility
+50.80%
Return
Best Daily Return
60 days
+20.73%
120 days
+20.73%
5 years
+20.73%
Worst Daily Return
60 days
-6.19%
120 days
-6.19%
5 years
-13.94%
Sharpe Ratio
60 days
+0.17
120 days
+1.08
5 years
+0.51
Risk Assessment
Maximum Drawdown
240 days
+48.00%
3 years
+48.00%
5 years
+67.74%
Return-to-Drawdown Ratio
240 days
-0.27
3 years
+1.86
5 years
+0.26
Skewness
240 days
+0.96
3 years
+0.93
5 years
+0.70
Volatility
Realised Volatility
240 days
+50.80%
5 years
+53.93%
Standardised True Range
240 days
+3.74%
5 years
+2.29%
Downside Risk-Adjusted Return
120 days
+214.65%
240 days
+214.65%
Maximum Daily Upside Volatility
60 days
+52.24%
Maximum Daily Downside Volatility
60 days
+42.50%
Liquidity
Average Turnover Rate
60 days
+0.75%
120 days
+0.64%
5 years
--
Turnover Deviation
20 days
+68.81%
60 days
+28.16%
120 days
+8.07%
Peer Comparison
Software & IT Services
Cellebrite DI Ltd
CLBT
8.05 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Amdocs Ltd
DOX
8.81 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cognizant Technology Solutions Corp
CTSH
8.76 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Mastercard Inc
MA
8.73 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Visa Inc
V
8.58 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
QXO Inc
QXO
8.54 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
FAQs
How does TradingKey generate the Stock Score of Cellebrite DI Ltd?
The TradingKey Stock Score provides a comprehensive assessment of Cellebrite DI Ltd based on 34 indicators derived from over 100 underlying data points. These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Cellebrite DI Ltd’s performance and outlook.
How do we generate the financial health score of Cellebrite DI Ltd?
To generate the financial health score of Cellebrite DI Ltd, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns. By integrating these comprehensive data, the financial health score not only reflects Cellebrite DI Ltd's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Cellebrite DI Ltd.
How do we generate the company valuation score of Cellebrite DI Ltd?
To generate the company valuation score of Cellebrite DI Ltd, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Cellebrite DI Ltd’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value. By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Cellebrite DI Ltd’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Cellebrite DI Ltd.
How do we generate the earnings forecast score of Cellebrite DI Ltd?
To calculate the earnings forecast score of Cellebrite DI Ltd, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.Comparing these indicators against peers provides context for the stock’s performance and helps
anchor more realistic expectations.These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Cellebrite DI Ltd’s future.
How do we generate the price momentum score of Cellebrite DI Ltd?
When generating the price momentum score for Cellebrite DI Ltd, we examine momentum indicators including support and resistance levels as well as volume metrics.Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.This comprehensive approach can reflect market sentiment and enable rational forecasts of Cellebrite DI Ltd’s prices. A higher score indicates a more stable short-term price trend for Cellebrite DI Ltd.
How do we generate the institutional confidence score of Cellebrite DI Ltd?
To generate the institutional confidence score of Cellebrite DI Ltd, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Cellebrite DI Ltd’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Cellebrite DI Ltd.
How do we generate the risk management score of Cellebrite DI Ltd?
To assess the risk management score of Cellebrite DI Ltd, we examine multiple key indicators related to returns, risk, volatility, and liquidity.The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.These indicators together provide a multi-dimensional understanding of Cellebrite DI Ltd’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Cellebrite DI Ltd.
